These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 8630629)

  • 21. Anti-inflammatory drugs, cyclooxygenases and other factors.
    Bennett A
    Expert Opin Pharmacother; 2001 Jan; 2(1):1-2. PubMed ID: 11336563
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Are COX-2 inhibitors as effective as conventional NSAIDs in acute pain states?
    Bannwarth B
    Arch Intern Med; 2001 Jan; 161(1):127-8. PubMed ID: 11146712
    [No Abstract]   [Full Text] [Related]  

  • 23. Interpreting the clinical significance of the differential inhibition of cyclooxygenase-1 and cyclooxygenase-2.
    Brooks P; Emery P; Evans JF; Fenner H; Hawkey CJ; Patrono C; Smolen J; Breedveld F; Day R; Dougados M; Ehrich EW; Gijon-Baños J; Kvien TK; Van Rijswijk MH; Warner T; Zeidler H
    Rheumatology (Oxford); 1999 Aug; 38(8):779-88. PubMed ID: 10501435
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of COX-1 and COX-2 in asthma pathogenesis and its significance in the use of selective inhibitors.
    Szczeklik A; Sanak M
    Clin Exp Allergy; 2002 Mar; 32(3):339-42. PubMed ID: 11940059
    [No Abstract]   [Full Text] [Related]  

  • 25. [Progress in the study of cyclooxygenase].
    Zhu H; Yang ZM
    Sheng Li Ke Xue Jin Zhan; 2004 Jan; 35(1):81-3. PubMed ID: 15127608
    [No Abstract]   [Full Text] [Related]  

  • 26. Cyclooxygenase inhibition and thrombogenicity.
    Catella-Lawson F; Crofford LJ
    Am J Med; 2001 Feb; 110 Suppl 3A():28S-32S. PubMed ID: 11173047
    [TBL] [Abstract][Full Text] [Related]  

  • 27. COX-2: a target for prevention and treatment of esophageal cancer.
    Altorki N
    J Surg Res; 2004 Mar; 117(1):114-20. PubMed ID: 15013721
    [No Abstract]   [Full Text] [Related]  

  • 28. COX2 selective NSAIDs and renal function: gain without pain?
    Breyer MD
    Kidney Int; 1999 Feb; 55(2):738-9. PubMed ID: 9987099
    [No Abstract]   [Full Text] [Related]  

  • 29. [What's in the future? New NSAIDs].
    Laufer S
    Pharm Unserer Zeit; 2002; 31(2):164-9. PubMed ID: 11977452
    [No Abstract]   [Full Text] [Related]  

  • 30. [COX-1 and COX-2: functions and pharmacological effects].
    Hinz B; Brune K
    Pharm Unserer Zeit; 1999 Jan; 28(1):21-9. PubMed ID: 10078026
    [No Abstract]   [Full Text] [Related]  

  • 31. [COX-2 inhibition: latest on NSAID].
    Z Orthop Ihre Grenzgeb; 1997; 135(1):Oa20-1. PubMed ID: 9199064
    [No Abstract]   [Full Text] [Related]  

  • 32. New perspectives for nonsteroidal antiinflammatory therapy.
    de Brum-Fernandes AJ
    J Rheumatol; 1997 Feb; 24(2):246-8. PubMed ID: 9034978
    [No Abstract]   [Full Text] [Related]  

  • 33. Cyclooxygenase-2 and colorectal cancer.
    DuBois RN
    Prog Exp Tumor Res; 2003; 37():124-37. PubMed ID: 12795052
    [No Abstract]   [Full Text] [Related]  

  • 34. [Pathogenesis of NSAID-induced gastric mucosal damage--search for primary events and role of COX inhibition].
    Takeuchi K; Tanaka A; Miyazawa T
    Nihon Shokakibyo Gakkai Zasshi; 2002 Jul; 99(7):751-9. PubMed ID: 12170703
    [No Abstract]   [Full Text] [Related]  

  • 35. Cyclo-oxygenase isoenzymes: physiological and pharmacological role.
    Kam PC; See AU
    Anaesthesia; 2000 May; 55(5):442-9. PubMed ID: 10792135
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prostaglandins and renal damage.
    Navarro JF
    J Am Soc Nephrol; 1996 Aug; 7(8):1245-6. PubMed ID: 8866420
    [No Abstract]   [Full Text] [Related]  

  • 37. Closing in on a stomach-sparing aspirin substitute.
    Service RF
    Science; 1996 Sep; 273(5282):1660. PubMed ID: 8830410
    [No Abstract]   [Full Text] [Related]  

  • 38. Selective COX-2 inhibitors: are they safe for the stomach?
    Yeomans ND; Cook GA; Giraud AS
    Gastroenterology; 1998 Jul; 115(1):227-9. PubMed ID: 9649482
    [No Abstract]   [Full Text] [Related]  

  • 39. The promise of coxibs: how far have we progressed?
    Schumacher HR
    J Pain Symptom Manage; 2002 Apr; 23(4 Suppl):S1-4. PubMed ID: 11992742
    [No Abstract]   [Full Text] [Related]  

  • 40. [New NSAIDS: COX-1, COX-2, what about them?].
    Peretz A
    Rev Med Brux; 1998 Sep; 19(4):A399-402. PubMed ID: 9805982
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.